Treatment of Systemic Mastocytosis With Tamoxifen

Location:

Rochester, Minn.

Trial status:

Open for Enrollment

Why is this study being done?

Not desired

Who is eligible to participate?

Inclusion Criteria: - Systemic Mastocytosis Exclusion Criteria: - Current treatment with Imatinib mesylate, cladribine or interferon alpha.

Last updated:

1/8/2014

NCT ID:

NCT01334996

IRB Number:

2506-04